- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
UPDATED May 03, 2024
High return on equity, past performance and sound balance sheet.
79 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
JSLL | ₹1,057.75 | 4.2% | 530.4% | ₹25.9b | n/a | PE48.2x | n/a | 0.1% | ||
4728 | NT$232.50 | 3.1% | -19.3% | NT$12.7b | n/a | PE20.2x | n/a | 4.1% | ||
SCYX | US$1.77 | 14.9% | -40.8% | US$67.2m | US$6.88 | PE1x | E0.04% | n/a | ||
PLX | US$1.14 | -0.9% | -65.1% | US$85.0m | US$13.00 | PE10.1x | E96.5% | n/a | ||
BVXP | UK£43.25 | -2.8% | 13.7% | UK£225.8m | UK£59.00 | PE26.1x | E5.2% | 3.5% | ||
PMC | ₫80,000.00 | -1.2% | 23.1% | ₫746.6b | n/a | PE12.3x | n/a | 18.8% | ||
ACCENTMIC | ₹270.40 | 1.4% | n/a | ₹5.7b | n/a | PE43.7x | n/a | 0% | ||
VLS | AU$2.26 | 0.9% | 52.2% | AU$126.0m | n/a | PE13.9x | n/a | 4.0% | ||
XCUR | US$0.50 | 0.2% | -52.7% | US$4.3m | n/a | PE1.4x | n/a | n/a | ||
CORT | US$24.52 | 7.5% | 1.9% | US$2.6b | US$43.60 | PE21.8x | E25.6% | n/a | ||
MEIP | US$3.06 | 0.3% | -52.6% | US$20.4m | US$23.00 | PE1x | E-47.4% | n/a | ||
IBT | CA$1.44 | 0% | 73.5% | CA$35.3m | n/a | PE8.9x | n/a | n/a | ||
600285 | CN¥25.45 | 0.6% | 47.4% | CN¥14.4b | n/a | PE23.4x | E11.5% | 2.4% | ||
506820 | ₹5,424.45 | 0.2% | 69.6% | ₹135.6b | n/a | PE97.4x | n/a | 0.3% | ||
6712 | NT$207.50 | 0.2% | 2.8% | NT$15.2b | n/a | PE28.2x | n/a | 1.7% | ||
6785 | NT$266.00 | -0.9% | 61.7% | NT$17.8b | n/a | PE46.4x | n/a | 0.6% | ||
540737 | ₹626.15 | -0.7% | 98.3% | ₹8.0b | n/a | PE36.6x | n/a | 0.08% | ||
DP3 | ₫65,000.00 | -1.7% | 62.5% | ₫1.4t | n/a | PE11.4x | n/a | 4.6% | ||
CTE | AU$0.82 | -3.5% | 7.9% | AU$40.0m | n/a | PE25.4x | n/a | 1.8% | ||
RPGLIFE | ₹1,471.45 | -6.1% | 87.9% | ₹24.3b | n/a | PE27.8x | n/a | 0.8% | ||
530477 | ₹206.20 | 42.8% | 160.7% | ₹6.5b | n/a | PE26.5x | n/a | 0.2% | ||
6817 | NT$127.00 | 0.4% | 46.0% | NT$2.3b | n/a | PE14.7x | n/a | 5.2% | ||
SPRO | US$1.63 | 11.6% | -16.4% | US$86.8m | US$7.50 | PE3.9x | E-2.9% | n/a | ||
GRIN | CA$1.00 | 2.0% | 471.4% | CA$226.9m | n/a | PE43.9x | n/a | n/a |